These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34641820)

  • 1. Tuberculosis-Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts.
    Cintron C; Narasimhan PB; Locks L; Babu S; Sinha P; Rajkumari N; Kaipilyawar V; Bhargava A; Maloomian K; Chandrasekaran P; Verma S; Joseph N; Johnson WE; Wanke C; Horsburgh CR; Ellner JJ; Sarkar S; Salgame P; Lakshminarayanan S; Hochberg NS
    BMC Infect Dis; 2021 Oct; 21(1):1058. PubMed ID: 34641820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RATIONS (Reducing Activation of Tuberculosis by Improvement of Nutritional Status) study: a cluster randomised trial of nutritional support (food rations) to reduce TB incidence in household contacts of patients with microbiologically confirmed pulmonary tuberculosis in communities with a high prevalence of undernutrition, Jharkhand, India.
    Bhargava A; Bhargava M; Velayutham B; Thiruvengadam K; Watson B; Kulkarni B; Singh M; Dayal R; Pathak RR; Mitra A; Rade K; Sachdeva KS
    BMJ Open; 2021 May; 11(5):e047210. PubMed ID: 34016663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) Model.
    Sinha P; Lakshminarayanan SL; Cintron C; Narasimhan PB; Locks LM; Kulatilaka N; Maloomian K; Prakash Babu S; Carwile ME; Liu AF; Horsburgh CR; Acuna-Villaorduna C; Linas BP; Hochberg NS
    Clin Infect Dis; 2022 Sep; 75(4):577-585. PubMed ID: 34910141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?
    Sivakumaran D; Jenum S; Ritz C; Vaz M; Doherty TM; Grewal HMS
    Front Immunol; 2022; 13():801616. PubMed ID: 35401549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
    PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of nutritional status and diabetes on active and latent tuberculosis: a cross-sectional analysis.
    Kubiak RW; Sarkar S; Horsburgh CR; Roy G; Kratz M; Reshma A; Knudsen S; Salgame P; Ellner JJ; Drain PK; Hochberg NS
    BMC Infect Dis; 2019 Jul; 19(1):627. PubMed ID: 31311495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent
    LaCourse SM; Richardson BA; Kinuthia J; Warr AJ; Maleche-Obimbo E; Matemo D; Cranmer LM; Escudero JN; Hawn TR; John-Stewart GC
    BMJ Open; 2020 Jan; 10(1):e034308. PubMed ID: 31969368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.
    Cox SR; Kadam A; Atre S; Gupte AN; Sohn H; Gupte N; Sawant T; Mhadeshwar V; Thompson R; Kendall E; Hoffmann C; Suryavanshi N; Kerrigan D; Tripathy S; Kakrani A; Barthwal MS; Mave V; Golub JE;
    Trials; 2022 Aug; 23(1):635. PubMed ID: 35932062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay.
    Kaul S; Nair V; Birla S; Dhawan S; Rathore S; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Malhotra P; Gupta D; Khanna A; Mohmmed A
    Microbiol Spectr; 2022 Apr; 10(2):e0244521. PubMed ID: 35416716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial.
    Bhargava A; Bhargava M; Meher A; Benedetti A; Velayutham B; Sai Teja G; Watson B; Barik G; Pathak RR; Prasad R; Dayal R; Madhukeshwar AK; Chadha V; Pai M; Joshi R; Menzies D; Swaminathan S
    Lancet; 2023 Aug; 402(10402):627-640. PubMed ID: 37567200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    Paradkar M; Padmapriyadarsini C; Jain D; Shivakumar SVBY; Thiruvengadam K; Gupte AN; Thomas B; Kinikar A; Sekar K; Bharadwaj R; Dolla CK; Gaikwad S; Elilarasi S; Lokhande R; Reddy D; Murali L; Kulkarni V; Pradhan N; Hanna LE; Pattabiraman S; Kohli R; S R; Suryavanshi N; B M S; Cox SR; Selvaraju S; Gupte N; Mave V; Gupta A; Bollinger RC;
    PLoS One; 2020; 15(7):e0236743. PubMed ID: 32726367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
    Abubakar I; Drobniewski F; Southern J; Sitch AJ; Jackson C; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Lynn W; Burgess H; Mann B; Imran A; Sridhar S; Tsou CY; Nikolayevskyy V; Rees-Roberts M; Whitworth H; Kon OM; Haldar P; Kunst H; Anderson S; Hayward A; Watson JM; Milburn H; Lalvani A;
    Lancet Infect Dis; 2018 Oct; 18(10):1077-1087. PubMed ID: 30174209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First insight into latent tuberculosis infection among household contacts of tuberculosis patients in Duhok, Iraqi Kurdistan: using tuberculin skin test and QuantiFERON-TB Gold Plus test.
    Abdulkareem FN; Merza MA; Salih AM
    Int J Infect Dis; 2020 Jul; 96():97-104. PubMed ID: 32243917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective longitudinal study of tuberculosis among household contacts of smear-positive tuberculosis cases in Lima, Peru.
    Otero L; Shah L; Verdonck K; Battaglioli T; Brewer T; Gotuzzo E; Seas C; Van der Stuyft P
    BMC Infect Dis; 2016 Jun; 16():259. PubMed ID: 27278655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.
    Petruccioli E; Chiacchio T; Navarra A; Vanini V; Cuzzi G; Cimaglia C; Codecasa LR; Pinnetti C; Riccardi N; Palmieri F; Antinori A; Goletti D
    J Infect; 2020 May; 80(5):536-546. PubMed ID: 32097688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.